Why the study?
Does BMS-182874 alter blood pressure, cardiac output, and total peripheral conductance in DOCA-salt hypertensive rats?
Does BMS-182874 alter blood pressure, cardiac output, and total peripheral conductance in DOCA-salt hypertensive rats?
Answers are grounded in this paper and cite their sources.
In DOCA-salt hypertensive rats, ETA receptor antagonism lowers blood pressure primarily by increasing total peripheral conductance rather than altering cardiac output.
The time-course changes in blood pressure (BP), cardiac output (CO), and total peripheral conductance (TPC) were investigated during a bolus i.v. infusion of BMS-182874, a selective ETA receptor antagonist, in conscious, unrestrained DOCA-salt hypertensive rats and Sham-operated control rats (SHAM). BP was recorded with radiotelemetry devices and CO with ultrasonic transit-time flow probes. In contrast to vehicle-treated controls, BMS-182874 reduced BP and increased TPC in DOCA-salt hypertensive rats but not in SHAM-rats. A small increase in CO tended to oppose the BP-lowering effect of the antagonist. The results suggest that the role of ETA receptors in the maintenance of the hypertensive state in the DOCA-salt model of hypertension is exerted at the level of the resistance vessels and not on factors that regulate CO.
No takes yet. Share an insight, caveat, or question.
Yu et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: